Proton Therapy For Pediatric Tumors
The aim of modern cancer treatment is to provide patients with the maximum chance of cure while minimizing treatment-related side effects. This can be achieved with proton therapy.
Under the pediatric treatment plan, the Prague Proton Therapy Center utilises state-of-the-art technology as well as the experience of leading Czech and foreign oncologists with proton therapy in children. All the children treated at the Proton Therapy Center are indicated for proton therapy in cooperation with one of the pediatric oncology centres. Today, over 80% of pediatric patients are successfully cured.
Treatment methods for pediatric tumors include surgery, radiation, chemotherapy and biological therapy. The choice of the type of specific treatment to be applied to your child depends on many factors and the treatment plan will be discussed with you in detail by the attending pediatric oncologist.
Radiotherapy (which also includes proton radiotherapy) is generally one of the basic therapeutic methods used to tackle cancer in children. It is used in patients either as the sole therapy or, more often, in combination with other methods (most frequently surgery, chemotherapy). In order to limit the adverse effects of radiation treatment, the current trend is to limit radiotherapy application to strictly selected situations, and if radiation is necessary, then to use the most advanced treatment methods such as proton radiotherapy.
Unlike commonly used radiation therapy, proton therapy is gentler and safer. Due to the precise proton beam targeting, we are able to significantly reduce the risk of adverse effects and to mitigate potential risks such as damage to the heart and lungs, the incidence of endocrine problems, growth disorders, impairment of sensory functions, intellectual impairment, damage to the kidneys and urinary tract, fertility impairment, and the emergence of secondary tumors.
What Tumors Is Proton Therapy Suitable For?
According to internationally recognised standards, proton therapy is most often indicated for the following diagnoses:
- low-grade malignant glioma;
- soft-tissue sarcomas;
- ewing’s sarcoma;